Search research articles
Contact Us
Filters
Showing results (81-90 of 138) with videos related to
Page
of 14
Sort By:
Blood Advances
|
November 23, 2020
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis
Ariela Noy, Sven de Vos, Morton Coleman, et al.
Leukemia & Lymphoma
|
March 29, 2021
Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience
Zachary D Epstein-Peterson, Nivetha Ganesan, Juliet N Barker, et al.
Blood
|
May 21, 2020
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)
Juan C Ramos, Joseph A Sparano, Amy Chadburn, et al.
Blood Advances
|
July 17, 2025
Novel Devimistat Results in Complete Remissions in Heavily Pre-Treated Burkitt Lymphoma in a phase II trial
Raphael E Steiner, Liana Nikolaenko, Ranjit Nair, et al.
Leukemia & Lymphoma
|
November 17, 2021
Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience
Terry K Pak, Brianne N Dixon, Michael J Buege, et al.
The Lancet. Haematology
|
August 2, 2023
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
Paul G Rubinstein, Page C Moore, Milan Bimali, et al.
Blood
|
December 22, 2009
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma
Joseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
Haematologica
|
August 30, 2023
Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good longterm outcomes
Paola Ghione, Salma Ahsanuddin, Efrat Luttwak, et al.
Blood
|
June 15, 2016
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial
Joseph C Alvarnas, Jennifer Le Rademacher, Yanli Wang, et al.
Haematologica
|
September 5, 2024
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience
Giulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 138) with videos related to
Sort By:
Page
of 14
Blood Advances
|
November 23, 2020
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis
Ariela Noy, Sven de Vos, Morton Coleman, et al.
Leukemia & Lymphoma
|
March 29, 2021
Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience
Zachary D Epstein-Peterson, Nivetha Ganesan, Juliet N Barker, et al.
Blood
|
May 21, 2020
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)
Juan C Ramos, Joseph A Sparano, Amy Chadburn, et al.
Blood Advances
|
July 17, 2025
Novel Devimistat Results in Complete Remissions in Heavily Pre-Treated Burkitt Lymphoma in a phase II trial
Raphael E Steiner, Liana Nikolaenko, Ranjit Nair, et al.
Leukemia & Lymphoma
|
November 17, 2021
Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience
Terry K Pak, Brianne N Dixon, Michael J Buege, et al.
The Lancet. Haematology
|
August 2, 2023
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
Paul G Rubinstein, Page C Moore, Milan Bimali, et al.
Blood
|
December 22, 2009
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma
Joseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
Haematologica
|
August 30, 2023
Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good longterm outcomes
Paola Ghione, Salma Ahsanuddin, Efrat Luttwak, et al.
Blood
|
June 15, 2016
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial
Joseph C Alvarnas, Jennifer Le Rademacher, Yanli Wang, et al.
Haematologica
|
September 5, 2024
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience
Giulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, et al.
Page
of 14